ensuring a high scientific level of this special, honorary issue for Steve.
I first met Steve in 1991, when he presented a poster during the annual American Epilepsy Society meeting. This initiated a long-lasting scientific dialogue and triggered an enduring friendship that matured over the years, and has expanded to include our families as well. While Steve's undisputed scientific merits are testified by publication of more than 200 full length papers, greater than 40 book chapters and numerous invited lectures at esteemed meetings, it never changed his humble and emphatic approach towards people. This attitude is what makes it a great pleasure to consider him a colleague and friend, but to also contribute to the respect and admiration that he so well deserves. [2] , the discoverer of Lacosamide, who praises Steve's leadership of pharmacological screening activities at the ASP resulting in the identification of the anticonvulsant properties of Lacosamide. Steve also holds a strong dedication to ensure that new research and therapies rapidly benefit patients, which is addressed and acknowledged by the last, and third, commentary by Susan Axelrod (Axelrod S, Neurochem Res, Special Issue for H. Steve White, 2017) [3] , Founding Chair of CURE. This is followed by unique expert reviews of animal models of seizures and epilepsy, the history and achievements of the ASP, and the prospects and strategy of the ETSP. Finally, this issue also contains a number of original papers and brief reviews on various topics of contemporary epilepsy research.
Steve is not only unique by his scientific contributions and behavior, he is also one of the very rare scientists that have the good fortune to see their research materialize into new treatment options, improving patient's lives, and generating hope for so many others. For all of these reasons and more, this Special Issue is very timely and so well deserved.
